• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

As their first clin­i­cal da­ta test looms, glob­al AI play­er In­sil­i­co bumps up a GSK vet to co-CEO in charge of ...

3 years ago
People
R&D

South Ko­re­an gi­ant's biotech arm to make $35M in­vest­ment in Irish fa­cil­i­ty

3 years ago
Manufacturing

Over­sight from FDA at phar­ma man­u­fac­tur­ing sites dipped dur­ing 2021 pan­dem­ic

3 years ago
FDA+
Manufacturing

NASH-fo­cused Akero Ther­a­peu­tics ex­tends its run­way by an­oth­er year with Pfiz­er's help

3 years ago
Financing

As PD-(L)1 dis­rup­tors suf­fer set­backs, Check­point touts an­oth­er win

3 years ago
R&D

Amidst large in­vest­ment from par­ent com­pa­ny, Sam­sung Bi­o­log­ics seeks to ramp up biotech fund­ing

3 years ago
Financing
Manufacturing

Gold­man Sachs leads a $300M round in­to a Chi­na biotech uni­corn boast­ing of its AI/ro­bot­ics prowess

3 years ago
Deals
R&D

Ex­elix­is taps in­to can­cer an­ti­body dis­cov­er­er out of Swe­den

3 years ago
Deals

Pfiz­er's dig­i­tal ther­a­peu­tics part­ner is back, this time in a new col­lab with Eli Lil­ly

3 years ago
Deals

Bavar­i­an Nordic to test its Covid-19 boost­er against Pfiz­er/BioN­Tech shot in piv­otal study

3 years ago
Coronavirus

One year af­ter wrap­ping PhI, Bio­gen drops ALS drug it bought from Karyopharm for $10M cash

3 years ago
Deals

A per­pet­u­al los­er at the high stakes game of Alzheimer's re­search, Roche con­cedes an­oth­er amy­loid flop

3 years ago
R&D

FDA's ad­comm votes unan­i­mous­ly in fa­vor of Mod­er­na and Pfiz­er's Covid-19 vac­cines for the youngest chil­dren

3 years ago
FDA+
Coronavirus

Bio­gen Foun­da­tion dou­bles down on next gen­er­a­tion STEM neu­ro­science to kick off its next decade

3 years ago
Pharma
Marketing

Supreme Court rules in fa­vor of hos­pi­tals over Medicare re­gard­ing 340B re­im­burse­ment pol­i­cy

3 years ago
Pharma
Law

Mak­e­na's ac­cel­er­at­ed ap­proval with­draw­al hear­ing set for Oc­to­ber as Co­vis wants to do more re­search

3 years ago
Pharma
FDA+

Pharm­Stars dig­i­tal health match­mak­er adds Roche to phar­ma spon­sor team as it preps a new chal­lenge

3 years ago
Pharma
Marketing

Sen­ate com­mit­tee ad­vances FDA user fee bill with ac­cel­er­at­ed ap­proval re­forms

3 years ago
FDA+

Brief­ing docs for Aca­di­a's Alzheimer's-re­lat­ed psy­chosis re­sub­mis­sion re­veal an un­de­cid­ed FDA

3 years ago
FDA+

Sh­iono­gi to pro­vide glob­al ac­cess to its an­tibi­otics, with fo­cus on poor coun­tries, as re­sis­tance fears grow

3 years ago
Deals
Pharma

Span­ish PM: Mod­er­na to in­vest $523M in­to the coun­try to boost vac­cine pro­duc­tion

3 years ago
Financing
Manufacturing

Two days af­ter show­ing strong pe­di­atric can­cer da­ta, Day One taps $150M in pub­lic cap­i­tal

3 years ago
Financing

No in­tro­duc­tions nec­es­sary: A TCR up­start with deep-pock­et back­ers part­ners with one of the new play­ers in the hot ...

3 years ago
Deals

Amid a fast launch, ten23 is look­ing to fur­ther ex­pand its man­u­fac­tur­ing out­put in Switzer­land

3 years ago
Manufacturing
First page Previous page 512513514515516517518 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times